91Ó°ÊÓ

Use the following data to answer the next five exercises: A pair of studies was performed to measure the effectiveness of a new software program designed to help stroke patients regain their problem solving skills. Patients were asked to use the software program twice a day, once in the morning and once in the evening. The studies observed 200 stroke patients recovering over a period of several weeks. The first study collected the data in Table 1.31. The second study collected the data in Table 1.32. $$\begin{array}{|l|l|l|}\hline \text { Group } & {\text { Showed improvement }} & {\text { No improvement }} & {\text { Deterioration }} \\ \hline \text { Used program } & {142} & {43} & {15} \\ \hline \text { Did not use program } & {72} & {110} & {18} \\ \hline\end{array}$$ Table 1.31 $$\begin{array}{|l|l|l|}\hline \text { Group } & {\text { Showed improvement }} & {\text { No improvement }} & {\text { Deterioration }} \\ \hline \text { Used program } & {105} & {74} & {19} \\ \hline \text { Did not use program } & {89} & {99} & {12}\\\ \hline\end{array}$$ Table 1.32 The company takes the two studies as proof that their software causes mental improvement in stroke patients. Is this a fair statement?

Step by step solution

01

Understanding the Data

First, we need to comprehend the information presented in the tables. The tables summarize the outcomes of stroke patients' conditions across two studies. The categories are 'Showed improvement', 'No improvement', and 'Deterioration', comparing users who used the program versus those who did not.

02

Analyze Table 1.31 Data

We'll calculate the percentage of patients who showed improvement in each group from Table 1.31. For 'Used program', the improvement percentage is \( \frac{142}{200} \times 100\% \approx 71\% \). For 'Did not use program', it's \( \frac{72}{200} \times 100\% \approx 36\% \).

03

Analyze Table 1.32 Data

Next, calculate the percentages for Table 1.32. For 'Used program', the improvement percentage is \( \frac{105}{198} \times 100\% \approx 53.03\% \). For 'Did not use program', it's \( \frac{89}{200} \times 100\% \approx 44.5\% \).

04

Comparing Results

Compare the improvement percentages for both tables. In Table 1.31, using the program shows a significantly higher percentage of improvement (71%) compared to not using it (36%). In Table 1.32, the difference is smaller (53.03% for users vs 44.5% for non-users), indicating less clear evidence in the second study.

05

Evaluating the Company's Statement

Based on the analysis, while Study 1 shows a substantial difference, Study 2 shows a less conclusive result. The mixed results suggest a potential positive effect, but it would not be fair to conclusively attribute all improvement to the software without considering other variables or conducting further studies.

Unlock Step-by-Step Solutions & Ace Your Exams!

• Full Textbook Solutions

  Get detailed explanations and key concepts

• Unlimited Al creation

  Al flashcards, explanations, exams and more...

• Ads-free access

  To over 500 millions flashcards

• Money-back guarantee

  We refund you if you fail your exam.

Over 30 million students worldwide already upgrade their learning with 91Ó°ÊÓ!

Key Concepts

These are the key concepts you need to understand to accurately answer the question.

Data Interpretation

Interpreting data effectively is crucial for drawing meaningful conclusions. In the case of the stroke patient studies, we have data presented in tables that show outcomes for two different groups: those who used the software program and those who did not.

Each table records three categories of patient outcomes: "Showed improvement," "No improvement," and "Deterioration." Our task is to understand what these categories represent and to compare the performance between the two groups.

• "Showed improvement" indicates a positive change in the patients' problem-solving abilities.
• "No improvement" suggests no significant change was observed.
• "Deterioration" reflects a decline in the patients' condition.

By analyzing this data, we aim to determine if there is significant evidence that supports the effectiveness of the new software in aiding recovery. Understanding the figures helps us in evaluating the claim of the company effectively. A careful interpretation prevents us from making faulty conclusions.

Percentage Calculation

Percentage calculations help quantify comparisons, particularly useful in this scenario. When extracting insights from Tables 1.31 and 1.32, we calculated the percentage of patients who showed improvements in each group to assess the software's impact.

For example, in Table 1.31, the percentage of patients who showed improvement using the program is calculated as follows:
* Divide the number of patients who showed improvement by the total number of patients using the program * Multiply the result by 100 to convert it into a percentage: \[ ext{Improvement Percentage for Program Users} = \frac{142}{200} \times 100\% \approx 71\% \] Similarly, calculating for patients who did not use the program gives us 36%.

Comparing these percentages helps in understanding the software's potential effectiveness. The substantial difference in Table 1.31 suggests a significant effect. However, performing similar calculations for Table 1.32 shows a narrower gap, reflecting less certainty.

This demonstrates why percentage calculation is a powerful tool for statistical analysis, enabling clear visual comparisons between groups.

Experimental Design

The design of an experiment significantly influences the validity of its conclusions. In these studies, the experimental design involves two groups of stroke patients, one using the program and one not using it. This approach allows researchers to determine if changes can be attributed to the software.

However, designing a fair test requires considering several important aspects:

• Random Assignment: Patients should be randomized into groups to prevent bias.
• Sample Size: Larger sample sizes can provide more reliable outcomes, reducing the margin of error.
• Control Variables: It's important to control other external factors that could influence results, like different rehabilitation therapies or patient demographics.

Such considerations ensure the study has robust internal validity, meaning observed effects are more likely due to the intervention rather than other variables.

In these studies, while we see some promising trends from the software, mixed results hint that design or external factors might be influencing outcomes. Thus, further detailed experiments with refined design would strengthen any claims made about the software's efficacy.